Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +971 (0) 4 368 1644
  • GDPR
  • Journalists
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +971 (0) 4 368 1644 from 8 AM - 5:30 PM GMT

    • Contact
    • Contact

      +971 (0) 4 368 1644
      from 8 AM - 5:30 PM GMT

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Queen Square Imaging Centre: New technique could improve outcomes for essential tremor patients
  • Middle East - Arabic
  • USA - Français
  • USA - English

Queen Square Logo

News provided by

Queen Square Imaging Centre

27 Oct, 2025, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

BILLINGSHURST, England, Oct. 27, 2025 /PRNewswire/ -- A new study by world-leading neurosurgeons Queen Square Imaging Centre in London has unveiled a breakthrough imaging technique that significantly enhances precision and outcomes of MR-guided focused ultrasound (MRgFUS) - a revolutionary, non-invasive treatment for essential tremor. 

Continue Reading
Left image shows an example of an image used for treatment elsewhere. Right shows an example of the FAT-1 images used by neurosurgeons at Queen Square Imaging Centre.
Left image shows an example of an image used for treatment elsewhere. Right shows an example of the FAT-1 images used by neurosurgeons at Queen Square Imaging Centre.

Affecting over a million people in the UK and millions more worldwide, essential tremor causes uncontrollable shaking, severely impacting an individual's quality of life. Medication is often the first line of treatment, but fails to help many patients long-term, often leading to more advanced interventions.

Now, a new technique using FAT1 imaging - a sophisticated MRI approach that fuses multiple scan types - is offering hope to patients.

A study in BMJ Neurology Open study reports the first use of FAT1 imaging to guide focused ultrasound for essential tremor. Traditionally, clinicians have relied on generalised brain maps to estimate the location of the target area within the brain - the Ventral Intermediate Nucleus (Vim) - which is extremely small and hard to visualise on standard MRI scans.

FAT1 imaging overcomes this by giving surgeons a direct view of the individual patient's Vim, enabling treatment to be precise.

"FAT1 imaging is a game-changer," said Mr Harith Akram, a consultant neurosurgeon at Queen Square Imaging who developed the technique and led the research. "By improving the visibility of the brain structures we need to target, we can deliver this non-invasive treatment with greater accuracy, faster results and fewer side effects, making a meaningful difference to patients' lives."

Study highlights:

  • 14 patients treated
  • 60% tremor reduction at 12 months
  • All reported better quality of life
  • Shorter-lasting, milder side effects
  • Faster procedures, less energy used, accurate targeting first time

Unlike traditional treatments such as Deep Brain Stimulation (DBS) or Radiofrequency Ablation (RFA), MRgFUS is completely non-invasive and incisionless. It focuses sound waves to gently heat and destroy the tremor-causing area of the brain under real-time MRI guidance.

With no surgery, no implants and a quicker recovery, MRgFUS is becoming the treatment of choice for eligible patients who do not respond to medication.

"This study represents the future of tremor treatment," added Mr Akram. "With new techniques like FAT1 imaging, we're able to personalise care in a way that is safer, smarter and more effective and ultimately give patients a better chance at regaining control and improving their quality of life."

Patients should always seek the advice from a professional and discuss their condition with a neurologist or movement disorder specialist for suitability.

Mr Harith Akram - consultant neurosurgeon at Queen Square Imaging Centre - developed the FAT-1 imaging technique and led the research.

Mr Akram is a pioneer of connectivity guided thalamic guided surgery for tremor and the Editor-in-chief of the World Society of Stereotactic and Functional Neurosurgery (WSSFNS) newsletter.

Study: San San Xu ,1,2 Harith Akram,1,2 Valentina Lind,1,2 Jonathan Hyam,1,2 Indran Davagnanam,3 Prasad Korlipara,2 Tabish A Saifee,2 Thomas Foltynie,1,2 Ludvic Zrinzo,1,2 Patricia Limousin,1,2 Marie T Kruger1,2,4. FAT1-weighted MRI-guided focused ultrasound thalamotomy for essential tremor. BMJ Neurology Open 2025;7:e001104. doi:10.1136/bmjno-2025-001104 

Additional supplemental material online:  https://doi.org/10.1136/bmjno-2025-001104 .

Queen Square Imaging Centre :

  • World-leading neuroimaging facility and diagnostic imaging facility, serving NHS and private patients.
  • The UK's only independent centre offering MRgFUS, Deep Brain Stimulation (DBS), Radiofrequency Ablation (RFA), and Gamma Knife Radiotherapy in one location.
  • Partnering with UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, all profits reinvested in neurological research, NHS services, and patient care.
  • Team includes world-leading specialists Professor Ludvic Zrinzo and Professor Patricia Limousin.

Photo - https://mma.prnewswire.com/media/2804696/QSI_new_imaging_technique.jpg
Logo - https://mma.prnewswire.com/media/2804695/Queen_Square_Logo.jpg

Modal title

Contact PR Newswire

  • +971 (0) 4 368 1644
    from 8 AM - 5:30 PM GMT

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+971 (0) 4 368 1644
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.